Evidence map›Paper›PMID 32145563›Full record

ArticleInternational journal of surgery case reports2020

Adult H3K27M-mutant diffuse midline glioma with gliomatosis cerebri growth pattern: Case report and review of the literature.

Anudeep Yekula, Mihir Gupta, Nicholas Coley, Hoi Sang U

Open access · goldAbstract readCase Reports
In one paragraph

Article in International journal of surgery case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Diffuse midline glioma H3K27M mutation in adult: A case report.Annals of medicine and surgery (2012) · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Anudeep YekulaDepartment of Neurosurgery, Massachusetts General Hospital Harvard Medical School, 185 Cambridge Street, Richard B. Simches Building 3rd Floor, Boston, MA, 02114, United States. Electronic address: ayekula@mgh.harvard.edu.
Mihir GuptaDepartments of Neurosurgery, UCSD Health, 9300 Campus Point Drive #MC7893, La Jolla, CA, 92037-1300, United States. Electronic address: mig044@health.ucsd.edu.
Nicholas ColeyDepartments of Neuropathology, University of California, UCSD Health, 9300 Campus Point Drive #MC7893, San Diego, La Jolla, CA, 92037-1300, United States. Electronic address: ncoley@health.ucsd.edu.
Hoi Sang UDepartments of Neurosurgery, UCSD Health, 9300 Campus Point Drive #MC7893, La Jolla, CA, 92037-1300, United States. Electronic address: hoisang@health.ucsd.edu.
UC San Diego Health System · USHarvard University · USUCLA Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionH3K27M-mutant diffuse midline glioma is a recently classified unique entity predominantly affecting pediatric patients and rarely adults. The clinicopathologic features in adults remain poorly characterized. PRESENTATION OF CASE: A 36-year-old man presented with subacute progressive cognitive and visual deterioration, and hydrocephalus requiring ventricular shunting. MRI revealed a diffusely infiltrating lesion with a gliomatosis cerebri growth pattern, multiple foci of contrast enhancement, and diffuse leptomeningeal involvement. Suboccipital craniotomy with exploration of the posterior fossa revealed a subtle capsular lesion infiltrating into the choroid plexus. Although histologically low-grade, the tumor was found to have an H3K27 M mutation establishing the diagnosis. DISCUSSION: In spite of diverse clinicopathologic characteristics, H3K27M-mutant diffuse midline gliomas are incurable, WHO grade IV lesions with poor prognosis. We discuss our case in the context of a review of published reports of H3K27-mutant diffuse midline gliomas in adults. Findings late in the disease course may mimic inflammatory or infectious pathologies radiographically, and low-grade infiltrative neoplasms histologically.

conclusionThe diverse clinical, radiographic and molecular features of H3K27M-mutant diffuse midline gliomas in adults remain to be completely characterized. A high index of suspicion is required to avoid missing the diagnosis. Early biopsy and detailed molecular characterization are critical for accurate diagnosis and patient counseling.

Indexed as

AdultBrain tumorDiffuse midline gliomaGliomatosis cerebriH3K27M mutationNeurosurgical biopsy

Identifiers

PMID32145563
PMCPMC7058855
OpenAlexW3007517390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.